In patients receiving pazopanib or sunitinib, high baseline serum IL8 levels were associated with shorter PFS and/or OS, suggesting that serum IL8 concentrations may be a prognostic or predictive factor for metastatic RCC (Liu et al, 2011; Tran et al, 2012; Harmon et al, 2014). One could ...